These results are consistent with previous studies that reported the implication of BCL2 and miR‐497 in cancer, including the CRC,12, 25, 26, 27 and support that analyzing combined markers is better than an individual molecule in cancer diagnostics and/or prognostication.28 The gene discussed is BCL2; the disease is colorectal carcinoma.